NCT05950711View on ClinicalTrials.gov

Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Major Depressive Disorder
Interventions
OTHER

Combination use of MBCT and IV Ketamine

Group with Major Depression who will receive a single dose of IV Ketamine embedded within a course of MBCT.

Trial Locations (1)

43210

Harding Hospital, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT05950711 - Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study | Biotech Hunter | Biotech Hunter